Number of the records: 1  

Efficacy and safety of trastuzumab emtansine plus capecitabine vs trastuzumab emtansine alone in patients with previously treated ERB2 (HER2)-positive metastatic breast cancer: a phase 1 and randomized phase 2 trial

  1. TitleEfficacy and safety of trastuzumab emtansine plus capecitabine vs trastuzumab emtansine alone in patients with previously treated ERB2 (HER2)-positive metastatic breast cancer: a phase 1 and randomized phase 2 trial
    Author infoCortés, J. ... [et al.]
    Co-authors Cortés J.
    Oravcová Eva
    Šufliarsky Jozef
    Corporation Redakcia Onkológia
    NoteJAMA Oncol. 2020 Jun 25;6(8):1-7
    Sign.C 3069
    Source Onkológia. - ISSN 1336-8176. - Bratislava : SOLEN , 2020 . - Roč. 15, č. 4 (2020), s. 304
    MeSH Subject nádory prsníka : farmakoterapia
    trastuzumab emtanzín : aplikácia a dávkovanie
    kapecitabín : aplikácia a dávkovanie
    farmakoterapia kombinovaná
    Form, Genre abstrakt v angličtine
    Subj. Headings karcinóm prsníka lokálne pokročilý HER2 pozitívny * účinnosť liečby * bezpečnosť liečby
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.